Abstract
Aim: To assess long-term effectiveness, complications, and outcomes of primary obstructive megaureter (POM) treated by endoscopic balloon dilation (EBD) in the largest series reported.Patients and Methods: Hundred POM in 92 consecutive patients were treated by EBD between years 2004 and 2016. A total of 79 POM (73 patients) with more than 18 months of follow-up after treatment have been analyzed. EBD of the vesicoureteral junction was performed with semicompliant high-pressure balloon catheters (2.7FG) with minimum balloon diameter of 5 mm, followed by temporary Double-J stent placement. Follow-up protocol included periodical clinical reviews, US and MAG-3 renogram scans.Results: Median age at surgery was 4 months (15 days−3.6 years), with median operating time of 20 min (10–60) and hospital stay of 1 day (1–7). Initial renal function was preserved in all patients with significant improvement in renal drainage on the MAG-3 diuretic renogram after endoscopic treatment (p < 0.001 T-test). Significant post-operative differences were observed in hydronephrosis grade and ureteral diameter that were maintained in the long-term (p < 0.001 T-test). Endoscopic approach of POM had a long-term success rate of 87.3%, with a mean follow-up of 6.4 ± 3.8 years. Secondary VUR was found in 17 cases (21.5%), being successfully treated by endoscopic subureteral injection in 13 (76.4%). Nine cases developed long-term re-stenosis (12.2%) that were successfully treated with a new EBD in 8. Endoscopic management of POM failed in 10 cases (12.7%) that required ureteral reimplantation. Five were early failures (4 intraoperative technical problems and 1 double-J stent migration with severe re-stenosis), and 5 long-term (4 persistent VUR and 1 re-stenosis recurrence).Conclusion: EBD has shown to be an effective treatment of POM with few complications and good outcomes at long-term follow up. Main complication was secondary VUR that could also be treated endoscopically with a high success rate. In our opinion, EBD may be considered first-line treatment in POM.
Highlights
Primary obstructive megaureter (POM) is a well-known entity in pediatric urology
Endoscopic management of POM failed in 10 cases (12.7%) that required open ureteral reimplantation (Table 3):
Endoscopic balloon dilation has shown to be a safe, feasible, and really less-invasive procedure in primary obstructive megaureter with surgical criteria even in small infants. We can consider it an effective treatment with few post-operative complications and good outcomes that maintains at long-term follow-up
Summary
Primary obstructive megaureter (POM) is a well-known entity in pediatric urology. Most patients only need conservative management since functional obstruction resolves spontaneously in most cases, during the first months of life, without renal impairment or symptoms [1]. Surgical treatment is reserved for those cases who develop progressive hydro-ureteronephrosis with urinary tract infections (UTI) and/or renal function loss. Its management and therapeutic options remain controversial. Ureteral reimplantation with or without ureteral tapering has been considered the gold-standard procedure for these patients, but in small infants, reimplantation of a huge ureter is challenging and it entails to potential complications [2]. Less-invasive procedures such endoscopic treatments have been proposed as alternative options in the initial management of POM, becoming so popular in the last years
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have